---
title: "Australia's CSL posts a 5% jump in first-half profit"
date: "2025-02-11 05:20:42"
summary: "Australia's CSL Ltd reported a 5% rise in its first-half profit on Tuesday, boosted by growth in its core immunoglobulin business across geographies.The biotech giant said that its underlying net profit after tax attributable for the six months ended December 31 was $2.11 billion, on a constant currency basis, compared..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Australia's CSL Ltd reported a 5% rise in its first-half profit on Tuesday, boosted by growth in its core immunoglobulin business across geographies.

The biotech giant said that its underlying net profit after tax attributable for the six months ended December 31 was $2.11 billion, on a constant currency basis, compared with $2.06 billion reported a year ago.

[Reuters](https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3P11OX:0-australia-s-csl-posts-a-5-jump-in-first-half-profit/)
